Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing.

Multi-Epitope-Ligand-Carthography (MELC) allows consecutive immunohistochemical visualization of up to 100 proteins on the same tissue sample. Subsequent biomathematical analysis of these images allows a quantitative description of changes in protein networks. We used the MELC technology to study the effect of the nonopioid analgesic drug dipyrone on protein network profiles associated with arachidonic acid-dependent signaling pathways. MELC analysis with 31 different fluorescence-labeled tags was used to compare the effect of dipyrone on protein networks in spinal cords of mice with zymosan-induced hyperalgesia, a common model for inflammatory pain. We found that the number of motifs which describe the colocalization of 5-lipoxygenase (5-LO) or 12-LO with other proteins increased disproportionally after dipyrone treatment. Activation of 5-LO and 12-LO induces their translocation to membrane compartments which was also reflected by MELC results. Although no changes in 5-LO or 12-LO expression were seen by Western blot analysis or by immunohistochemistry in spinal cords of dipyrone-treated mice, the activation of both enzymes was verified by determining LO-products. Spinal amounts of 5(S)-hydroxyeicosatetraenoic acid (HETE) and 12(S)-HETE, which are generated by 5-LO and 12-LO, respectively, were significantly increased in spinal cords of dipyrone-treated animals. In primary spinal cord neurons, dipyrone selectively and dose-dependently increased 5(S)-(HETE) and 12(S)-HETE synthesis. Thus, we show for the first time that monitoring protein network profiles by topological proteomic analysis is a useful tool to identify mechanisms of drug actions.

[1]  R. Botting,et al.  Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Levine,et al.  Contribution of 5- and 12-lipoxygenase products to mechanical hyperalgesia induced by prostaglandin E2 and epinephrine in the rat , 2003, Experimental Brain Research.

[3]  Min-Xia Wang,et al.  Expression and regulation of peroxiredoxin 5 in human osteoarthritis , 2002, FEBS letters.

[4]  E. E. Bagley,et al.  Cellular Actions Of Opioids And Other Analgesics: Implications For Synergism In Pain Relief , 2000, Clinical and experimental pharmacology & physiology.

[5]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[6]  K. Scholich,et al.  Is mPGES-1 a promising target for pain therapy? , 2006, Trends in pharmacological sciences.

[7]  S. Karpatkin,et al.  Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. , 2007, Blood.

[8]  W. Schubert,et al.  Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.

[9]  K. Scholich,et al.  Toponomics Analysis of Functional Interactions of the Ubiquitin Ligase PAM (Protein Associated with Myc) during Spinal Nociceptive Processing*S , 2008, Molecular & Cellular Proteomics.

[10]  M. Michaelis,et al.  Inhibition of Cyclooxygenases by Dipyrone , 2007, British journal of pharmacology.

[11]  E. Puré,et al.  Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis , 2006, Proceedings of the National Academy of Sciences.

[12]  R. Sittl,et al.  The Effects on Platelet Aggregation and Prostanoid Biosynthesis of two Parenteral Analgesics: Ketorolac Tromethamine and Dipyrone , 1996, Thrombosis and Haemostasis.

[13]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[14]  L. Audoly,et al.  Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages* , 2005, Journal of Biological Chemistry.

[15]  H. Huang,et al.  Regulation of cyclooxygenase and 12-lipoxygenase catalysis by phospholipid hydroperoxide glutathione peroxidase in A431 cells. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  Katherine B Percarpio,et al.  Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.

[17]  C. Serhan,et al.  Resolvins and protectins in the termination program of acute inflammation. , 2007, Trends in immunology.

[18]  C. Brenneis,et al.  Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice , 2007, Journal of cellular and molecular medicine.

[19]  F. Gago,et al.  Regulation of cyclooxygenase activity by metamizol. , 1999, European journal of pharmacology.

[20]  B. Giusti,et al.  Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  B. Uretsky,et al.  Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production , 2008, The Journal of Immunology.

[22]  O. Werz,et al.  5-Lipoxygenase: regulation of expression and enzyme activity. , 2007, Trends in biochemical sciences.

[23]  L. Philipsen,et al.  Ulcerative Colitis Response Profiles in Crohn's Disease and Mucosa Reveals Distinctive Immune Proteomic Analysis of the Inflamed Intestinal , 2007 .

[24]  G. Geisslinger,et al.  Cerebrospinal fluid prostaglandins after systemic dipyrone intake , 1998, Clinical pharmacology and therapy.

[25]  O. Werz,et al.  Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells. The presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. , 1996, European journal of biochemistry.

[26]  F. Hofmann,et al.  Cysteine-Rich Protein 2, a Novel Downstream Effector of cGMP/cGMP-Dependent Protein Kinase I-Mediated Persistent Inflammatory Pain , 2008, The Journal of Neuroscience.

[27]  Walter Schubert,et al.  Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures , 2007, Nature Protocols.

[28]  K. Honn,et al.  12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes. , 1995, Prostaglandins.

[29]  L. Philipsen,et al.  Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. , 2008, Cancer research.

[30]  B. Bonnekoh,et al.  Topo-Proteomic in situ Analysis of Psoriatic Plaque under Efalizumab Treatment , 2007, Skin Pharmacology and Physiology.

[31]  P. Jakobsson,et al.  Inhibition of prostaglandin E2 synthesis by SC‐560 is independent of cyclooxygenase 1 inhibition , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  V. Gutierrez,et al.  The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators , 2008, Pharmacology Biochemistry and Behavior.

[33]  D. Steinhilber,et al.  Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Imlay,et al.  Pathways of oxidative damage. , 2003, Annual review of microbiology.

[35]  A. Ottani,et al.  Dual acting anti-inflammatory drugs. , 2007, Current topics in medicinal chemistry.

[36]  O. Werz,et al.  Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  H. Seyberth,et al.  Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. , 1999, Journal of the American Society of Nephrology : JASN.

[38]  J. Lindgren,et al.  15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. , 2000, Biochimica et biophysica acta.

[39]  M. Romano Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. , 2006, Inflammation & allergy drug targets.